T

Tyra Biosciences

Develops precision oncology therapies targeting FGFR

Senior Director - GMP Quality Assurance

Regulatory & Quality (Life Sciences)Updated on Nov 10
Full-timeRemote in USA$290.5k - $317.5k

About the Job

Requirements

  • A bachelor's degree in Chemistry, Biochemistry, Pharmacy, Chemical Engineering, or a related discipline and 15 or more years of pharmaceutical GMP Quality Assurance experience, including 8 or more years in a people leadership role.
  • Extensive experience overseeing outsourced small molecule drug substance and solid oral dose drug product manufacturing through contract development and manufacturing organizations in a sponsor company environment.
  • Demonstrated experience supporting late-stage programs through NDA submission, including Process Performance Qualification campaigns and FDA Pre-Approval Inspections.
  • Comprehensive knowledge of 21 CFR Parts 11, 210, and 211, EU GMP, ICH Q7–Q10 and Q12, and Good Distribution Practices.
  • Experience hosting regulatory inspections, conducting supplier audits, and negotiating Quality Agreements.
  • Experience using an electronic Quality Management System, such as Veeva Vault, MasterControl, or TrackWise.
  • Ability to communicate effectively and make risk-based decisions while balancing strategic and tactical responsibilities in a fast-paced biotech environment.

Responsibilities

  • Develop and execute the GMP Quality Assurance strategy in alignment with the Global Quality vision and company objectives for clinical supply, NDA submissions, and commercial launch.
  • Build and lead a high-performing GMP QA team, scale internal and outsourced resources in a phase-appropriate manner, and manage the GMP QA budget.
  • Serve as the GMP Quality representative on CMC, Supply Chain, and program teams, providing guidance on FDA, EMA, MHRA, and ICH requirements.
  • Provide quality oversight of CDMOs, contract testing laboratories, and packagers, maintaining strong QA-to-QA relationships.
  • Review and approve batch records, deviations, investigations, out-of-specification results, and change controls, ensuring robust root cause analysis and effective CAPA.
  • Author, negotiate, and approve Quality Agreements with CDMOs and GMP vendors.
  • Provide quality oversight of technology transfer, validation, stability, and Process Performance Qualification activities in preparation for NDA submissions.
  • Own batch disposition of drug substance, drug product, and clinical supplies, including Qualified Person certification processes with external QPs.
  • Oversee Good Distribution Practices for storage and distribution, including temperature excursions, complaints, recalls, and commercial readiness for serialization and DSCSA.
  • Lead the risk-based GMP and GDP supplier qualification and audit program in collaboration with Quality Systems.
  • Lead inspection readiness for FDA Pre-Approval Inspections and international health authority inspections, and support review of quality sections of regulatory submissions, such as NDA Module 3.
  • Develop and approve GMP and GDP Standard Operating Procedures, and report GMP quality metrics at Management Review and to senior leadership.

Desired Qualifications

  • An advanced degree (M.S., Ph.D., or Pharm.D.) or professional certification, such as ASQ CQA or CPGP.
  • Experience supporting commercial product launches, including serialization and DSCSA compliance.
  • Experience establishing Qualified Person release processes and supporting global marketing authorization applications.
  • Experience in oncology or precision medicine programs.

About the Company

Tyra Biosciences

Develops precision oncology therapies targeting FGFR

Tyra Biosciences develops precision medicines for cancer and genetically defined diseases using its SNAP platform to target specific genetic mutations. Its lead programs include TYRA-300, an FGFR3 inhibitor for achondroplasia and non-muscle invasive bladder cancer, and TYRA-200, an FGFR1/2/3 inhibitor for intrahepatic cholangiocarcinoma and other solid tumors. The SNAP platform supports mutation-focused drug design to overcome resistance and tailor therapies, aided by collaborations with academic partners to advance trials. Funding comes from venture capital and public offerings, with future revenue expected from drug sales and licensing upon regulatory approval, and the goal of bringing targeted, effective treatments to patients by moving candidates through clinical development toward commercialization.

Company size
51-200
Company stage
IPO
Headquarters
Carlsbad, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Tyra Biosciences

See more jobs